News & Announcements
The AMP PD project will focus on identifying and validating promising biomarkers that may be useful in tracking the progression of Parkinson’s disease and could serve as biological targets for the development of new drugs.
Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the AMP RA/SLE Phase I study are now available to the research community.
Sponsors and supporters of gene drive research, including the FNIH, respond to a National Academies report.
Spotlight
Learn more about Dr. Freire in this “Women in Business” Q&A featured in the Huffington Post.
These international business awards recognize the world's premiere female entrepreneurs, executives, employees and organizations. The FNIH and Dr. Freire were winners in the categories: Organization of the Year and Woman of the Year.
The FNIH is delighted to once again earn the highest, 4-star rating from Charity Navigator, in addition to being named the #1 charity among biomedical research organizations.